Director, Intercontinental Medical Market Lead, Neuroscience at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Advanced degree preferred (e.g., Pharm D, PhD, MD)
10+ years of relevant bio-pharmaceutical industry experience

Responsibilities

Bring a strong market voice on AIMS (Asset Indication Medical Strategy), and ensure bi-directional alignment between WW Medical and Medical Leadership in Markets for a given region
Communicate the priorities, needs, and potential risks of non-AIMS markets
Partner closely with Disease Area Medical Product Leads (MPLs) to ensure AIMS deliverables are executed across the Markets
Provide visibility to Market data gaps and evidence needs and offer guidance on impact to Integrated Evidence Plans (IEP) and disease area medical plans
Raise opportunities for collaborative studies and innovative platforms aligned with prioritized evidence gaps to WW disease area Medical, Medical Evidence Generation, Scientific Collaborations & Alliances Leads and the Digital Health team
Establish strong relationships and networks with WW cross-functional partners such as Medical Product Leads, Medical Communications teams, Commercial & Access leads, Field Medical Excellence (FME), Medical Evidence Generation (MEG) and Health Economics and Outcomes Research (HEOR) to be a reliable and knowledgeable resource and ensure a seamless interface with respective Markets
Serve as the primary liaison between WW Medical (TA) and the TA Medical Leadership in the markets (non-AIMS) to ensure bi-directional alignment, communication & execution around assets/disease and TA strategy
Leverage clinical and scientific expertise to drive adoption of the TA global medical strategy across global medical teams, in alignment with TA Medical Heads
Understand country and region launch needs and priorities, distill key risks or opportunities, and communicate them to regional leadership and AIMS
Address WW and local launch or execution issues and risks, facilitating resolution and mitigation as appropriate
Collaborate with CMD and Markets TA Medical Head to identify lifecycle management opportunities and data gaps, informing strategy and prioritization of studies
Provide visibility on non-AIMS market needs and insights and interpret WW portfolio outputs for local execution
Connect local teams with WW Medical for support, ensure effective communication, and identify and remove market roadblocks
Foster cross-functional collaboration, promote inclusiveness and accountability, and manage budgets in partnership with cross-functional teams

Skills

Medical Affairs

Neuroscience

Strategic Alignment

Cross-functional Collaboration

Market Intelligence

Stakeholder Management

Risk Assessment

Evidence Generation

Global Medical Strategy

Disease Area Expertise

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free